Price Crosses Moving Average
Previous Close | 23.35 |
Open | 24.04 |
Bid | 25.01 x 900 |
Ask | 26.78 x 800 |
Day's Range | 23.78 - 26.01 |
52 Week Range | 13.19 - 31.42 |
Volume | |
Avg. Volume | 406,044 |
Market Cap | 1.209B |
Beta (5Y Monthly) | 2.67 |
PE Ratio (TTM) | 46.27 |
EPS (TTM) | 0.56 |
Earnings Date | Jul 25, 2023 - Jul 31, 2023 |
Forward Dividend & Yield | 0.04 (0.17%) |
Ex-Dividend Date | May 05, 2023 |
1y Target Est | 22.81 |
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories Inc.'s ( NYSE:CLB ) price-to-earnings (or "P/E") ratio of 42.9x might make it look like a strong sell...
We're definitely into long term investing, but some companies are simply bad investments over any time frame. We really...
This morning, I'm joined by Chris Hill, Core's chief financial officer; and Gwen Gresham, Core's senior vice president and head of investor relations. Gwen will start by making remarks regarding forward-looking statements.
Core Labs (CLB) expects second-quarter 2023 revenues of $130-$135 million, earnings of 20-24 cents per share and operating income of $14.5-$17.5 million.
Core Laboratories (CLB) delivered earnings and revenue surprises of 11.76% and 1.66%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Core Laboratories N.V. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2023 revenue of $128,400,000. Core's operating income was $6,500,000, with diluted earnings per share ("EPS") of $0.05, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $14,500,000, yielding operating margins over 11%, and EPS, ex-items, of $0.19. During the first quarter of 2023, the Company recorded: 1) ap
OPEC members surprised the market with another oil production cut, which lifted these small-cap oil-related stocks.
Halliburton (HAL), Core Labs (CLB) and Schlumberger Ltd. (SLB) are likely to have been impacted by poor sentiment, rising costs, and weak prices in Q1. These factors might impact profitability & rising break-even prices.
Core Laboratories (NYSE: "CLB") will broadcast its first quarter 2023 conference call over the Internet at 7:30 a.m. CDT / 2:30 p.m. CEST on April 27, 2023.
Ariel Investments, an investment management company, released its “Ariel Small-Cap Value Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. In the fourth quarter, the Ariel Small Cap Value Tax-Exempt Composite gained 13.37% gross of fees compared to an 8.42% return for the Russell 2000 Value Index and a 6.23% gain for […]
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Alger Capital, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. During the quarter, Class A shares of the fund underperformed the Russell 2500 Growth Index. The fund returned 3.01% (without sales charges) compared to 4.72% for the benchmark. The […]
A big inventory build in the U.S. and fears of higher interest rates caused these oil-related stocks to fall.
Core Laboratories N.V. (NYSE:CLB) Q4 2022 Earnings Call Transcript February 2, 2023 Operator: Good morning, and welcome to the Core Laboratories Fourth Quarter 2022 Earnings Call. All participants will be in listen-only mode. . After today’s presentation, there will be an opportunity to ask questions. . Please note this event is being recorded. I would […]
Core Labs' (CLB) revenues for the first quarter of 2023 are anticipated in the $125-$129 million range, while the operating income is estimated in the $11.5-$14.5 million band.
This morning, I'm joined by Chris Hill, Core's chief financial officer; and Gwen Gresham, Core's senior vice president and head of investor relations. Gwen will start by making remarks regarding forward-looking statements.
Core Laboratories (CLB) delivered earnings and revenue surprises of 5.26% and 1.83%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Core Laboratories N.V. (NYSE: CLB) ("Core", "Core Lab", or the "Company") reported fourth quarter 2022 revenue of $127,600,000. Core's operating income was $15,600,000, with diluted earnings per share ("EPS") of $0.14, all in accordance with U.S. generally accepted accounting principles ("GAAP"). The financial results for the fourth quarter of 2022 include a non-cash adjustment of $1,900,000, decreasing stock compensation expense associated with performance share awards that vested during the qu
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Core Labs plans to relocate from the Netherlands to the United States to increase shareholder value over time by streamlining its corporate structure, enhancing operational effectiveness and reducing cost.
Core Laboratories N.V. (NYSE: "CLB US") ("Core", "Core Lab", or the "Company") announces the Company's Board of Directors has approved a plan to reorganize the Company's corporate structure, which will include redomestication of the parent company from the Netherlands to the United States (the "Redomestication"). The Company and its Board believes that the Redomestication will enhance shareholder value over the long-term through simplifying the corporate structure, improving operational efficien
Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its fourth quarter 2022 conference call over the Internet at 7:30 a.m. CST / 2:30 p.m. CET on February 2, 2023.
In this article, we will be taking a look at the 10 small cap stocks with wide moats. To skip our detailed analysis of wide moat stocks, you can go directly to see the 5 Small Cap Stocks With Wide Moats. The beginning of 2022 saw big losses for small-cap stocks, but this soon began […]
Alger Capital, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” third quarter investor letter. A copy of the same can be downloaded here. During the quarter, Class A shares of the fund underperformed the Russell 2500 Growth Index. The Information technology and Industrials sectors contributed to the fund’s relative performance in the quarter, […]